Skip to main content
Fig. 4 | Lipids in Health and Disease

Fig. 4

From: Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut–liver axis

Fig. 4

a p-AMPK protein expression in each group compared by one-way ANOVA followed by the Dunnett T3 multiple comparison test. ##P < 0.01 compared with Group N, **P < 0.01 compared with Group M. b–d Nfr2, TLR-4, and p-p65 protein expression in each group compared by one-way ANOVA followed by the least significant difference (LSD) multiple comparison test. ##P < 0.01 compared with Group N, **P < 0.01 compared with Group M. e–g TNF-α, IL-1β, and IL-6 levels in each group were compared by one-way ANOVA followed by the least significant difference (LSD) multiple comparison test. ##P < 0.01 compared with Group N, **P < 0.01 compared with Group M

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X